U.S. Markets close in 3 hrs 58 mins

Nivalis Therapeutics, Inc. (NVLS)


NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
2.37+0.05 (+2.16%)
As of 11:41AM EDT. Market open.
People also watch
KLACLRCXTERNSMLLTC
Interactive chart
Previous Close2.32
Open2.33
Bid2.37 x 100
Ask2.38 x 1500
Day's Range2.33 - 2.42
52 Week Range2.00 - 9.35
Volume15,427
Avg. Volume302,390
Market Cap37.11M
BetaN/A
PE Ratio (TTM)-1.17
EPS (TTM)-2.03
Earnings DateJul 31, 2017 - Aug 4, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Shire (SHPG) Beats on Q1 Earnings & Sales, Reiterates View
    Zacks19 days ago

    Shire (SHPG) Beats on Q1 Earnings & Sales, Reiterates View

    Shire plc (SHPG) reported first-quarter 2017 earnings of $3.63 per American Depositary Share (ADS), beating the Zacks Consensus Estimate of $3.22 and up 13.8% from the year-ago quarter figure of $3.19.

  • AMAG Pharma (AMAG) Incurs Loss in Q1, Revenues Rise Y/Y
    Zacks19 days ago

    AMAG Pharma (AMAG) Incurs Loss in Q1, Revenues Rise Y/Y

    AMAG Pharmaceuticals, Inc. (AMAG) reported adjusted earnings of 99 cents per share in the first quarter of 2017 compared with earnings of 68 cents in the year-ago quarter

  • Associated Press21 days ago

    Nivalis Therapeutics reports 1Q loss

    The Boulder, Colorado-based company said it had a loss of 57 cents per share. Losses, adjusted for restructuring costs, were 35 cents per share. In the final minutes of trading on Monday, the company's ...